Original Research
Published on 17 Apr 2023
Synergistic antitumor activity of regorafenib and rosuvastatin in colorectal cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1136114
- 3,016 views
- 7 citations
Type at least 3 characters
2,604 articles
Articles
Original Research
Published on 13 Apr 2023
Chlorophenyl thiophene silicon phthalocyanine: Synthesis, two-photon bioimaging-guided lysosome target, and in vitro photodynamic efficacy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1168393
- 1,729 views
- 2 citations
Editorial
Published on 13 Apr 2023
Editorial: Anti-cancer bioactive molecules from microbial sources
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1190354
- 2,414 views
- 1 citation
Original Research
Published on 13 Apr 2023
Surface engineered mesoporous silica carriers for the controlled delivery of anticancer drug 5-fluorouracil: Computational approach for the drug-carrier interactions using density functional theory
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1146562
- 2,352 views
- 4 citations
Original Research
Published on 13 Apr 2023
Comparison of pneumonitis risk between immunotherapy alone and in combination with chemotherapy: an observational, retrospective pharmacovigilance study
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1142016
- 3,682 views
- 2 citations
Review
Published on 13 Apr 2023
Role of ferroptosis and its non-coding RNA regulation in hepatocellular carcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1177405
- 2,728 views
- 3 citations
Original Research
Published on 12 Apr 2023
I13 overrides resistance mediated by the T315I mutation in chronic myeloid leukemia by direct BCR-ABL inhibition
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1183052
- 2,029 views
- 5 citations
Correction
Published on 12 Apr 2023
Corrigendum: Adenosine kinase on deoxyribonucleic acid methylation: Adenosine receptor-independent pathway in cancer therapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1200491
- 789 views
Original Research
Published on 11 Apr 2023
Cuproptosis-related molecular subtypes direct T cell exhaustion phenotypes and therapeutic strategies for patients with lung adenocarcinoma
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1146468
- 5,529 views
- 6 citations
Original Research
Published on 11 Apr 2023
GPR35 antagonist CID-2745687 attenuates anchorage-independent cell growth by inhibiting YAP/TAZ activity in colorectal cancer cells
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1126119
- 3,392 views
- 5 citations
Original Research
Published on 10 Apr 2023
A novel signature of cuproptosis-related lncRNAs predicts prognosis in glioma: Evidence from bioinformatic analysis and experiments
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1158723
- 2,699 views
- 5 citations
Review
Published on 07 Apr 2023
Challenges of EGFR-TKIs in NSCLC and the potential role of herbs and active compounds: From mechanism to clinical practice
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1090500
- 4,550 views
- 7 citations
Original Research
Published on 06 Apr 2023
L-carnitine prevents lenvatinib-induced muscle toxicity without impairment of the anti-angiogenic efficacy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1182788
- 2,102 views
Review
Published on 06 Apr 2023
The role of cholesterol metabolism in tumor therapy, from bench to bed
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.928821
- 5,155 views
- 7 citations
Systematic Review
Published on 06 Apr 2023
Therapy-resistant breast cancer in focus: Clinically relevant mitigation by flavonoids targeting cancer stem cells
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1160068
- 2,585 views
- 3 citations
Review
Published on 06 Apr 2023
Cell- and subcellular organelle-targeting nanoparticle-mediated breast cancer therapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1180794
- 2,575 views
- 5 citations